Lilly Officially Pleads Guilty In Zyprexa Debacle

Law360, New York (January 30, 2009, 12:00 AM EST) -- Weeks after Eli Lilly & Co. announced a record-breaking $1.4 billion deal to settle charges that it illegally marketed its anti-psychotic treatment Zyprexa for off-label use, the pharmaceutical giant formally pled guilty Friday to a misdemeanor related to the scandal.

The U.S. Attorney's Office for the Eastern District of Pennsylvania said Lilly — which had already agreed to the plea — officially pled guilty at a hearing in federal court in Philadelphia to “the introduction into interstate commerce of quantities of its drug, Zyprexa, that were...
To view the full article, register now.